The
medical imaging segments are poised for a major new phase of growth
fueled by the availability of new technology coming out of the computer
and digital information technology segment. Continuous improvements in
technology are resulting in a growing number of new imaging tests that
combine high levels of accuracy with rapid, easy-to-use product formats.
Part of that medical imaging improvement is coming from positron
emission tomography (PET). PET is a scanning technique used in
combination with small amounts of radio-labeled compounds to visualize
the anatomy and function of the brain. The purpose of this Publications
report is to describe the specific market segment of the diagnostics
medical imaging market called PET scanning. This sector includes all of
the generally accepted imaging activities that are currently used in
PET, including equipment for PET, PET/CT, SPECT and the use of
radiopharmaceuticals for imaging. It examines these clinical measurement
devices and their reagents and supplies as used in hospitals and
clinics. It also reviews associated clinical market segments in which
PET scanning has taken a prominent role including cancer treatment,
cardiology and neurology imaging markets.
1. Overview 61.1 Statement of Report 6
1.2 Scope of the Report 8
1.3 Objectives 9
1.4 Methodology 9
1.5 Executive Summary 9
2. Overview of Diagnostic Point of Care Testing 112.1 Key Issues in the Point of Care Diagnostic Testing Sector 11
2.1.1 Current Market Trends and Drivers 11
2.1.2 Effectiveness of POCT 12
2.1.3 New Growth Areas for POCT 13
2.1.4 Advantages of POCT in a Clinical Setting 13
2.1.5 Pricing and Reimbursement Issues 13
2.1.6 Key Customer Segments 13
2.2 Global Point of Care Marketplace 13
2.3 Shifts from Central-Lab Testing to POCT 15
2.4 Geographical Distribution 15
2.5 Emerging New Technologies 16
2.6 Challenges of POCT 17
2.7 Key Issues for POCT 17
2.7.1 Locations of POCT 17
2.7.2 Hospital Lab Rapid Tests 18
2.7.3 Doctor’s Office Laboratory 18
2.7.4 Non-Hospital POCT 18
2.7.5 Home Monitoring 19
2.7.6 Milestones in Technology Development 20
2.7.7 Drive for Decentralization from Lab to Patient 20
2.7.8 Expanded Reimbursement 20
2.7.9 Competitive Landscape for POCT 23
2.8 The Future of POCT 23
3. POC and Rapid Testing: Market Analysis: Size, Background, Growth, Share and Competitors 243.1 Global POCT Market 26
3.2. U.S. Point of Care Markets 27
3.3. European POCT Market 32
3.4. Japanese POCT Market 35
For more information, please visit:
http://www.aarkstore.com/reports/Positron-Emission-Tomography-PET-Markets-1338.html
Or email us at press@aarkstore.com or call +919272852585
1. Overview 61.1 Statement of Report 6
1.2 Scope of the Report 8
1.3 Objectives 9
1.4 Methodology 9
1.5 Executive Summary 9
2. Overview of Diagnostic Point of Care Testing 112.1 Key Issues in the Point of Care Diagnostic Testing Sector 11
2.1.1 Current Market Trends and Drivers 11
2.1.2 Effectiveness of POCT 12
2.1.3 New Growth Areas for POCT 13
2.1.4 Advantages of POCT in a Clinical Setting 13
2.1.5 Pricing and Reimbursement Issues 13
2.1.6 Key Customer Segments 13
2.2 Global Point of Care Marketplace 13
2.3 Shifts from Central-Lab Testing to POCT 15
2.4 Geographical Distribution 15
2.5 Emerging New Technologies 16
2.6 Challenges of POCT 17
2.7 Key Issues for POCT 17
2.7.1 Locations of POCT 17
2.7.2 Hospital Lab Rapid Tests 18
2.7.3 Doctor’s Office Laboratory 18
2.7.4 Non-Hospital POCT 18
2.7.5 Home Monitoring 19
2.7.6 Milestones in Technology Development 20
2.7.7 Drive for Decentralization from Lab to Patient 20
2.7.8 Expanded Reimbursement 20
2.7.9 Competitive Landscape for POCT 23
2.8 The Future of POCT 23
3. POC and Rapid Testing: Market Analysis: Size, Background, Growth, Share and Competitors 243.1 Global POCT Market 26
3.2. U.S. Point of Care Markets 27
3.3. European POCT Market 32
3.4. Japanese POCT Market 35
For more information, please visit:
http://www.aarkstore.com/reports/Positron-Emission-Tomography-PET-Markets-1338.html
Or email us at press@aarkstore.com or call +919272852585
No comments:
Post a Comment